Skip to main content
Clinical Trials/NCT03749811
NCT03749811
Unknown
Not Applicable

Comparison of Remifentanil Consumption in Pupillometry-guided Versus Conventional Administration in Pediatric Surgery: a Prospective, Randomized Controlled Trial

Seoul National University Hospital1 site in 1 country60 target enrollmentDecember 4, 2018
ConditionsOpioid Use

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid Use
Sponsor
Seoul National University Hospital
Enrollment
60
Locations
1
Primary Endpoint
remifentanil total dose in microgram
Last Updated
7 years ago

Overview

Brief Summary

Our study aims to compare the total intravenous dose of remifentanil per anesthesia hour and body weight in two groups of pediatric surgical patients - an interventional group with remifentanil infusion under pupillometry monitoring, and control group without pupillometry - to figure out whether pupillometry monitoring may reduce remifentanil consumption during anesthesia while providing sufficient analgesia for surgical noxious stimuli.

Detailed Description

comparison of total used opioid

Registry
clinicaltrials.gov
Start Date
December 4, 2018
End Date
November 18, 2021
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hee-Soo Kim

princial investigator

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Pediatric patients who are at 3 to 6 years of age, scheduled to undergo elective surgery with estimated time of operation 2 hours or longer, under general anesthesia
  • American Society of Anesthesiologists physical status classification (ASA class) I - II
  • Patient and his/her parents are willing to participate after explanation of the purpose, materials, methods, possible risks and benefits of the research

Exclusion Criteria

  • History of hypersensitivity/allergic reaction to the drugs which are used in general anesthesia
  • Preoperative use of analgesics, antipsychotics and/or antiepileptics
  • Mental retardation
  • Medications related to hindrance of autonomic nerve system activity, e. g., beta blockers
  • Underlying ophthalmic diseases

Outcomes

Primary Outcomes

remifentanil total dose in microgram

Time Frame: from beginning of anesthesia to the end of the anesthesia

Remifentanil total dose divided by anesthesia time (minute) and patient weight (kg).

FLACC score

Time Frame: Arrival at the post-anesthesia care unit

FLACC score (a pain evaluation method for children who cannot express their severity of pain verbally) right after post-anesthesia care unit arrival.

Adjusted analgesic dose after anesthesia

Time Frame: 24 hours after the end of anesthesia

Total dose of analgesics (NSAIDs and opioids) delivered to the patient since the end of the anesthesia, until 24 hours after the end of anesthesia

Secondary Outcomes

  • Emergence time(Intraoperative)
  • Incidence of rescue therapy(Intraoperative)

Study Sites (1)

Loading locations...

Similar Trials